Profil bibliographique

Luděk Pour

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

231Publications signalées

3974Citations signalées

2Affiliations récentes

Institutions déclarées

Masaryk University University Hospital Brno

Domaines associés

Multiple Myeloma Research and TreatmentsCancer Treatment and PharmacologyProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisChronic Lymphocytic Leukemia Research

Publications récentes

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S3 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 otherOpenAlex

Data from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S1 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S2 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S1 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S4 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Table S2 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Methods 1 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 supplementary-materialsOpenAlex

Supplementary Figure S3 from Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citations

Accès ouvert 2026 articleOpenAlex

Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma

Maximilian Merz, Tomáš Jelı́nek, Thomas Pabst, Raphael Teipel et autres

0 citationsBlood Cancer Discovery

Accès ouvert 2026 articleOpenAlex

High‐risk genomic features predict extramedullary progression in multiple myeloma with paraskeletal plasmacytomas

Martin Štork, Eva Ondroušková, Johana Mayerová, Andrea Marečková et autres

0 citationsHemaSphere

Accès ouvert 2026 articleOpenAlex

P25 | REAL-WORLD OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA: EVIDENCE SUPPORTING BORTEZOMIB–LENALIDOMIDE–DEXAMETHASONE AS A PREFERRED REGIMEN WITHOUT ANTI-CD38 ANTIBODIES

A. Jungova, M. Stork, I Spicka, J. Radocha et autres

0 citationsHaematologica

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.